Skip to main content
OpenTrials
Completed

NCT Number: NCT00651001

Metabolic Syndrome and Leptin Level Associated With Fructose Consumption in Spain

A Food Frequency Questionnaire (FFQ), will be provided to 800 adults to assess overall fructose intake and this will be related to a number of features related to the metabolic syndrome, including serum leptin, characteristic features of metabolic syndrome (body mass index, waist circumference, plasma lipids, blood pressure, HOMA index,fasting glucose and fasting insulin levels) and other as: CRP, fibrinogen, homocysteine and uric acid.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Healthy Glucose Metabolism Disorders Hyperinsulinism Inflammation Insulin Resistance Metabolic Diseases Metabolic Syndrome Nutritional and Metabolic Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Renal Unit of Mateo Orfila Hospital, Balearic Islands - Spain

Menorca, Balearic Islands, 07703, Spain

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults, 18-70 years of age

Exclusion criteria

  • Diabetes
  • Kidney Failure
  • Heart Failure
  • Cancer

Treatment and study plan

Primary outcomes

  1. Serum leptin levels as it relates to fructose intake

    Time frame: Epidemiological association

Secondary outcomes

  1. Relationship of metabolic syndrome features with fructose intake. This includes measuring all 5 components of metabolic syndrome, assessing insulin resistance by HOMA, and measuring some markers of inflammation (CRP, fibrinogen, homocysteine)

    Time frame: Epidemiological

Sponsors and collaborators

Lead sponsor

Hospital Mateo Orfila

Other

Registry information

Official study title

Prevalence of Cardiovascular Risk Factors in Minorca - Spain

Important dates

Study start
2008
Primary completion
2009
Study completion
2009
First posted
Apr 2, 2008
Registry last updated
Aug 6, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.